Concepedia

Author

Pieter van Paassen

Maastricht UniversityORCID

Also Known As

Martin Witzenrath, Novikov, Pavel, P Paassen, P Van Paassen, P van Paassen, P. Paassen, P. VAN PAASSEN, P. Van PAASSEN, P. Van Paassen, P. van Paassen

220

Publications

8.6K

Citations

48

H-Index

104

Concepts

All Affiliations

Maastricht UniversityMaastricht University Medical CentreUniversity Medical Center GroningenUniversity Medical Center UtrechtAmsterdam University Medical Centers
PV

About

Pieter van Paassen is an author at Maastricht University specializing in medicine, pathology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

22

25

2.1K

2

Health Sciences

3

3

301

3

Public Health

2

2

102

4

Engineering

1

1

14

5

Applied Physiology

1

1

25

Pieter van Paassen

×

81

Publications

6.6K

Citations

38

H-Index

YearCitations

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

Rachel Jones, Jan Willem Cohen Tervaert, Thomas Häuser,

New England Journal of Medicine

2010

1.7K

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial

Rachel Jones, Shunsuke Furuta, Jan Willem Cohen Tervaert,

Annals of the Rheumatic Diseases

2015

263

Cardiac involvement in Churg‐Strauss syndrome

Robert Dennert, Pieter van Paassen, Simon Schalla,

Arthritis & Rheumatism

2010

213

ANCA as a Predictor of Relapse

Michael J. Kemna, Jan Damoiseaux, Jos Austen,

Journal of the American Society of Nephrology

2014

208

Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS

Caspar I. van der Made, Judith Potjewijd, Annemiek Hoogstins,

Journal of Allergy and Clinical Immunology

2021

203

Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial

Alexander P. J. Vlaar, Sanne de Bruin, Matthias H. Busch,

The Lancet Rheumatology

2020

198

Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays

Jan Damoiseaux, Elena Csernok, Niels Rasmussen,

Annals of the Rheumatic Diseases

2016

193

Analyses of immunosenescent markers in patients with autoimmune disease

Mariëlle Thewissen, Veerle Somers, Koen Venken,

Clinical Immunology

2007

157

Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities

Sjoerd A.M.E.G. Timmermans, Myrurgia A. Abdul‐Hamid, Joris Vanderlocht,

Kidney International

2017

141

Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: Eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis

Mark R. Hazebroek, Michael J. Kemna, Simon Schalla,

International Journal of Cardiology

2015

140

Page 1